In Situ Surface Modification of Microfluidic Blood–Brain-Barriers for Improved Screening of Small Molecules and Nanoparticles

Модификация поверхности микрофлюидных гематоэнцефалических барьеров in situ для улучшенного скрининга малых молекул и наночастиц
Nicolas Hans Voelcker, Helmut W. Thissen, Christopher D. Easton, Bo Peng, Ziqiu Tong, Wing Yin Tong, Paul J. Pasic, Arianna Oddo, Yitian Dai, Meihua Luo, Juliette Frescene, Nicholas G. Welch
2020-11-23

BBB permeabilityin situ surface modificationmicrofluidic blood–brain barriernanoparticle transcytosisphotocrosslinkable copolymer
Here, we have developed and evaluated a microfluidic-based human blood–brain-barrier (μBBB) platform that models and predicts brain tissue uptake of small molecule drugs and nanoparticles (NPs) targeting the central nervous system. By using a photocrosslinkable copolymer that was prepared from monomers containing benzophenone and N -hydroxysuccinimide ester functional groups, we were able to evenly coat and functionalize μBBB chip channels in situ, providing a covalently attached homogenous layer of extracellular matrix proteins. This novel approach allowed the coculture of human endothelial cells, pericytes, and astrocytes and resulted in the formation of a mimic of cerebral endothelium expressing tight junction markers and efflux proteins, resembling the native BBB. The permeability coefficients of a number of compounds, including caffeine, nitrofurantoin, dextran, sucrose, glucose, and alanine, were measured on our μBBB platform and were found to agree with reported values. In addition, we successfully visualized the receptor-mediated uptake and transcytosis of transferrin-functionalized NPs. The BBB-penetrating NPs were able to target glioma cells cultured in 3D in the brain compartment of our μBBB. In conclusion, our μBBB was able to accurately predict the BBB permeability of both small molecule pharmaceuticals and nanovectors and allowed time-resolved visualization of transcytosis. Our versatile chip design accommodates different brain disease models and is expected to be exploited in further BBB studies, aiming at replacing animal experiments.
1
An in situ photocrosslinked copolymer coating enabled homogeneous covalent attachment of extracellular-matrix proteins to chip channels.
2
Developed a microfluidic human blood–brain-barrier platform that models and predicts brain uptake of small molecules and nanoparticles.
3
Measured permeability coefficients for multiple reference compounds agreed with reported values, supporting the platform’s predictive accuracy.
4
The platform supported coculture of human endothelial cells, pericytes, and astrocytes, forming cerebral endothelium-like barriers with tight-junction markers and efflux proteins.
5
The versatile microfluidic design supports different brain disease models and may help reduce reliance on animal experiments.
6
Transferrin-functionalized nanoparticles showed receptor-mediated uptake and transcytosis, reached 3D-cultured glioma cells, and could be visualized over time.

The microfluidic human blood–brain-barrier (μBBB) platform with in situ surface-functionalized chip channels and cocultured brain endothelial cells, pericytes, and astrocytes

The platform’s ability to reproduce BBB properties and accurately predict the permeability, receptor-mediated uptake, transcytosis, and brain-compartment targeting of small molecules and nanoparticles

Publication Details
Publication Date
2020-11-23
Journal
Publisher
ISSN
Cited by
75
Access Type
Author Information
Authors
Nicolas Hans Voelcker
Helmut W. Thissen
Christopher D. Easton
Bo Peng
Ziqiu Tong
Wing Yin Tong
Paul J. Pasic
Arianna Oddo
Yitian Dai
Meihua Luo
Juliette Frescene
Nicholas G. Welch
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%